SCHEMBL547503

SCHEMBL547503

Cc1ccc(S(=O)(=O)[O-])cc1.Cc1ccc([S+](c2ccccc2)c2ccccc2)c(C)c1C

nearest known ligand 0.38

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
CA12 O43570 4/20 0.37
CA9 Q16790 4/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 2/20 0.36
MAPK1 P28482 1/20 0.36
THPO P40225 1/20 0.36
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 4/20 0.36
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31072151 1.00 BCHE (0.38) BCHEACHELMNATDP1CA12
SCHEMBL4585181 0.94 LMNA (0.40) BCHEACHELMNATDP1CYP3A4
SCHEMBL4861374 0.84 RAPGEF4 (0.40) BCHEACHELMNATDP1CA12
SCHEMBL3127290 0.83 CA12 (0.40) BCHEACHELMNATDP1CA12
SCHEMBL7133269 0.82 CA12 (0.47) BCHEACHELMNATDP1CA12
SCHEMBL64189 0.82 CA12 (0.47) BCHEACHELMNATDP1CA12
SCHEMBL3759626 0.82 TSHR (0.35) ACHELMNACYP1A2ALOX12
SCHEMBL2964104 0.81 CA12 (0.46) BCHEACHELMNATDP1CA12
SCHEMBL3144525 0.81 CA12 (0.46) BCHEACHELMNATDP1CA12
P-Xylene SCHEMBL3404430 0.81 GAA (0.46) BCHEACHELMNATDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346723-A1 TELLURIUM-CONTAINING POLYMER AND COMPOUND THE SCHOOL CORPORATION KANSAI UNIV (JP) 2025-11-13 US disclosed
WO-2025005020-A1 LITHOGRAPHY FILM-FORMING COMPOSITION, LITHOGRAPHY UNDERLAYER FILM, AND RESIST PATTERN FORMING METHOD 学校法人 関西大学 2025-01-02 WO disclosed
WO-2024224654-A1 POLY-ARM-TYPE RESIN HAVING POLYAMIDE STRUCTURE OR HETEROCYCLIC STRUCTURE, LITHOGRAPHY FILM-FORMING COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD 学校法人 関西大学 2024-10-31 WO disclosed
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-26 US disclosed
WO-2023214589-A1 TELLURIUM-CONTAINING POLYMER AND COMPOUND 学校法人 関西大学 2023-11-09 WO disclosed
US-20230333469-A1 FILM FORMING COMPOSITION FOR LITHOGRAPHY, RESIST PATTERN FORMATION METHOD, AND CIRCUIT PATTERN FORMATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-10-19 US disclosed
US-20230185191-A1 COMPOUND, PRODUCTION METHOD THEREFOR, ACID GENERATOR, COMPOSITION, RESIST FILM, UNDERLAYER FILM, PATTERN FORMATION METHOD, AND OPTICAL COMPONENT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-06-15 US disclosed
US-20230174688-A1 COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-06-08 US disclosed
CN-115836045-A Composition for forming photoresist, method for forming resist pattern, and method for forming circuit pattern 三菱瓦斯化学株式会社 2023-03-21 CN disclosed
CN-115605517-A Compound, (co) polymer, composition, resist pattern forming method, and method for producing compound and (co) polymer 三菱瓦斯化学株式会社(JP) 2023-01-13 CN disclosed
EP-2474518-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN Mitsubishi Gas Chemical Company, Inc. (JP) 2012-07-11 EP disclosed
EP-2474565-A1 CYCLIC COMPOUND, MANUFACTURING METHOD THEREFOR, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMING A RESIST PATTERN Mitsubishi Gas Chemical Company, Inc. (JP) 2012-07-11 EP disclosed
US-20120171615-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-07-05 US disclosed
US-20120171379-A1 RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-07-05 US disclosed
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-28 US disclosed
US-20120164575-A1 CYCLIC COMPOUND, MANUFACTURING METHOD THEREFOR, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMING A RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-28 US disclosed
US-20120156615-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-21 US disclosed
US-8110334-B2 Radiation-sensitive composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-02-07 US disclosed
US-20100047709-A1 RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2010-02-25 US disclosed
EP-2080750-A1 RADIATION-SENSITIVE COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2009-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346723-A1 TELLURIUM-CONTAINING POLYMER AND COMPOUND TEX10, TEX13A, RNF4 BCHE 3378/4885ACHE 2623/4885LMNA 3445/4885
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin SLC39A11, CROCC, TERB1 BCHE 613/4885ACHE 1890/4885LMNA 772/4885
US-20230185191-A1 COMPOUND, PRODUCTION METHOD THEREFOR, ACID GENERATOR, COMPOSITION, RESIST FILM, UNDERLAYER FILM, PATTERN FORMATION METHOD, AND OPTICAL COMPONENT SOAT2, SOAT1, FAR1 BCHE 1520/4885ACHE 2426/4885LMNA 2297/4885
US-20230174688-A1 COMPOUND, (CO)POLYMER, COMPOSITION, METHOD FOR FORMING RESIST PATTERN, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING (CO)POLYMER MCCC2, MMAB, INTS9 BCHE 2953/4885ACHE 4368/4885LMNA 4013/4885
US-20120171379-A1 RADIATION-SENSITIVE COMPOSITION PARG, RAD51, SRMS BCHE 4482/4885ACHE 4830/4885LMNA 469/4885
US-20100047709-A1 RADIATION-SENSITIVE COMPOSITION C1S, C9, RAD51 BCHE 4597/4885ACHE 4853/4885LMNA 286/4885
US-20120156615-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, CCNE1, CCNA1 BCHE 3131/4885ACHE 4531/4885LMNA 559/4885
US-20120171615-A1 CYCLIC COMPOUND, PROCESS FOR PRODUCTION OF THE CYCLIC COMPOUND, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, CCNE1, CCNA1 BCHE 3131/4885ACHE 4531/4885LMNA 559/4885
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, RER1, REV1 BCHE 3844/4885ACHE 4609/4885LMNA 298/4885
US-20120164575-A1 CYCLIC COMPOUND, MANUFACTURING METHOD THEREFOR, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMING A RESIST PATTERN WEE1, SLC11A2, RAD1 BCHE 3515/4885ACHE 4708/4885LMNA 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.